Skip to main content
Novartis Home

Language & Country Selector for Desktop

language-selector-globe Global | en

Choose Location

  • International
  • Americas
  • Europe
  • Middle East & Africa
  • Asia Pacific
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Latin America | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh

Language & Country Selector for Mobile

language-selector-globe Global

Choose Location

International Americas Europe Middle East & Africa Asia Pacific
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latin America | es
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Board of Directors
        • Joerg Reinhardt
        • Simon Moroney
        • Nancy Andrews
        • Ton Buechner
        • Patrice Bula
        • Elizabeth Doherty
        • Ana de Pro Gonzalo
        • Bridgette Heller
        • Daniel Hochstrasser
        • Frans van Houten
        • Andreas von Planta
        • Charles Sawyers
        • William Winters
        • Charlotte Pamer-Wieser
      • Executive Committee
        • Vasant Narasimhan
        • Shreeram Aradhye, M.D.
        • James Bradner
        • Victor Bulto
        • Karen Hale
        • Harry Kirsch
        • Rob Kowalski
        • Steffen Lang
        • Klaus Moosmayer
        • Richard Saynor
        • Marie-France Tschudin
        • Lutz Hegemann
        • Michael Willi
        • Kees Roks
      • Strategy
        • People and Culture
        • Data and Digital
      • Products
      • Innovative Medicines
      • Sandoz
      • Operations
        • Global Biotech Cooperations
      • Diversity & Inclusion
        • Equity
        • Diversity & Inclusion Governance and Community
        • Inclusivity
        • Parental Leave
        • Society
      • Quality
        • Audit program
        • Novartis Quality Management System (QMS)
        • Product and patient safety training
        • Regulatory inspections
        • Product recalls
        • Third-party suppliers
      About Novartis
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Patient Organization Funding
      • Adverse Event Reporting
      • COVID-19: Patients and Caregivers
      • Stories: Patients Perspectives
      Patients & Caregivers
    • Healthcare Professionals
      • Medical Congresses and Events
        • Abstract summaries for EULAR
        • Abstract summaries for ACR
        • Abstract summaries for EADV
      • Products
      • Novartis Pipeline
      • Managed Access Programs
        • Novartis Gene Therapies Managed Access Program
      • Novartis External Funding
      • Healthcare Professional Resources by Country
      • Investigator-Initiated Trials / Studies
      • Transparency and Disclosure
      Healthcare Professionals
    • Research & Development
      • Novartis Institutes for BioMedical Research
        • Collaborations
        • NIBR Global Scholars Program
      • Technology Platforms
        • Radioligand Therapy
        • Gene Therapy
        • Cell Therapy
      • Research Disease Areas
        • Immuno-oncology research at Novartis
        • Oncology research at Novartis
        • Cardiovascular and metabolic disease research at Novartis
        • Autoimmunity, transplantation and inflammatory disease research at Novartis
        • Ophthalmology research at Novartis
        • Neuroscience Research at Novartis
        • Musculoskeletal Disease Research at Novartis
        • DAx: exploratory disease research at Novartis
      • Research Locations
        • Novartis Institute for Tropical Diseases
      • Novartis Pipeline
      • Translational Medicine
      • Research & Development Approach
      • Stories from our Labs
      • Open Source Science
      Research & Development
    • ESG
      • Access
        • Creating sustainable business models
        • Value-Based Pricing
        • Sub-Saharan Africa
        • Donations
        • Novartis Access Principles
        • Novartis Oncology Access
        • Patents and Licensing
      • Ethics, Risk and Compliance
        • Ethical Behavior
        • Compliance
        • Human Rights
        • Learning and Engagement
        • Risk management
      • Environmental Sustainability
        • Climate
        • Waste
        • Water
      • Global Health
        • Anti-Microbial Resistance (AMR)
        • Avoidable Blindness
        • Chagas Disease
        • Leprosy
        • Malaria
        • Sickle Cell Disease (SCD)
        • Novartis Foundation
      • Diversity & Inclusion
      • Reporting
        • Environmental, Social and Governance (ESG) Index
        • ESG Rating Performance
        • Codes, Policies and Guidelines
        • Materiality Assessment
        • Transparency and Disclosure
        • Targets
        • Positions
      Environmental, Social and Governance
    • Investors
      • Event Calendar
      • Financial Data
        • Novartis Annual Results
        • Novartis Quarterly Results
        • Novartis SEC Filings
        • Product Sales
        • Fixed-Income Securities
        • Expected Currency Impact
      • Share Data & Analysis
        • Share Monitor
        • Dividend Information
        • Share Ownership
        • Share Overview
      • Shareholder Information
        • General Meetings
        • American Depository Receipts (ADR)
        • Share Buy-Back
        • Frequently Asked Questions
      • Company Overview
        • Corporate Governance
      • Novartis Annual Reporting Suite
        • Reporting Archive
        • Publications Order Form
      • ESG
      Investors
    • News
      • News Archive
      • Media Library
      • Stories
      • Subscribe
      News
    • Careers
      • Career Search
      • Our Teams
        • Careers in Commercial
        • Careers in Communications and Advocacy
        • Careers in Consulting
        • Careers in Digital
        • Careers in Health, Safety & Environment
        • Careers in Information Technology (IT)
        • Careers in Medical & Development
        • Careers in People & Organization
        • Careers in Procurement
        • Careers in Research
        • Careers in Strategy
        • Careers in Manufacturing and Supply
        • Ethics, Risk & Compliance (ERC)
        • Careers in Legal
      • Career Programs
        • Community Exploration & Learning Lab (CELL)
      • Early Talent
      • Postdoc Program
        • Andreas Bender, PhD
        • Boxun Lu, PhD
        • The Novartis Innovation Postdoctoral Fellowship
        • The Novartis Discovery Postdoctoral Fellowship
        • Postdoc Research Themes
        • Recognition
        • Postdoc Program Leadership
      • International Careers
      • Learning and Development
      • Well-being
      • Internship Programs
      Careers
    • COVID-19 Information Center
      COVID-19 Novartis response
    • Clinical Trials
      Clinical Trials
    • Partnering
      Partnering
    • Contacts
      Contacts
    Home
  1. Home
  2. Careers
  3. Career Search
  4. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date
Job Title Site Location Division Business Functional Area Date
Sr. Principal Process & Training Lead Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 23, 2022
Expert EDO Spot Lead Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 23, 2022
Clinical/Pharmacovigilance Quality Assurance Manager Bangkok Thailand Global Drug Development QA GDD Quality May 23, 2022
Clinical Scientific Expert - I Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 23, 2022
EDO Relationship Lead Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 23, 2022
Clinical Data Manager Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 23, 2022
Associate Expert Science & Technology – Sample Management (m/f/d) Schaftenau Austria Global Drug Development TECHNICAL R & D GDD Research & Development May 23, 2022
Clinical Data Manager Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 23, 2022
Head of Operations, Global Clinical Supply (m/f/d) Basel Switzerland Global Drug Development TECHNICAL R & D GDD Research & Development May 20, 2022
Regulatory Coordinator- LCM Hyderabad, AP India Global Drug Development REG AFFAIRS GDD Research & Development May 20, 2022
Clinical Development Head - Immunology **80-100% Basel Switzerland Global Drug Development IHD DU GDD Research & Development May 20, 2022
Director/Senior Director Epidemiologist East Hanover, NJ USA Global Drug Development CMO & PATIENT SAFETY GDD Research & Development May 20, 2022
Sample Management & Stability Associate Durham, NC USA Global Drug Development TECHNICAL R & D GDD Quality May 20, 2022
Expert, Science & Technology - Analytical Method Validation East Hanover, NJ USA Global Drug Development TECHNICAL R & D GDD Quality May 20, 2022
Regulatory Affairs CMC Director (Biologics) East Hanover, NJ USA Global Drug Development REG AFFAIRS GDD Research & Development May 20, 2022
Senior Expert Data Science Hyderabad, AP India Global Drug Development CMO & PATIENT SAFETY GDD Data Science May 19, 2022
Patient Safety Specialist | Part time (50%), Temp Tel Aviv Israel Global Drug Development CMO & PATIENT SAFETY GDD Research & Development May 19, 2022
Principal Statistical Programmer Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 19, 2022
Japan Program Head Tokyo Japan Global Drug Development IHD DU GDD Research & Development May 19, 2022
Sr Principal Clin Data Stds Specialist Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 19, 2022
Senior Global Trial Manager Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 19, 2022
Clinical Development Medical Director, Gene Therapies Chicago, IL USA Global Drug Development CMO GTX Research & Development May 19, 2022
Associate Expert, Science & Technology (QC Analyst/Sr Analyst) San Diego, CA USA Global Drug Development TECHNICAL R & D GDD Quality May 19, 2022
Strategic Site Partnership Lead-West (Remote) San Diego, CA USA Global Drug Development GDO GDD Research & Development May 19, 2022
Associate, PV Compliance &Process Tokyo Japan Global Drug Development CMO & PATIENT SAFETY GDD Research & Development May 18, 2022
Senior Risk Management Manager Hyderabad, AP India Global Drug Development CMO & PATIENT SAFETY GDD Research & Development May 18, 2022
Senior Expert Engineering Schaftenau Austria Global Drug Development TECHNICAL R & D GDD Research & Development May 18, 2022
Associate Director Science & Technology (f/m/d) Schaftenau Austria Global Drug Development TECHNICAL R & D GDD Research & Development May 18, 2022
Analytical Project Leader - Sen. Expert Sci.&Tec. SI/CH/AT/DE (m/f/d) Menges Slovenia Global Drug Development TECHNICAL R & D GDD Research & Development May 18, 2022
Principal Clinical Data Manager Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 18, 2022
Principal Clinical Data Manager Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 18, 2022
Analytical Project Lead - Asso. Dir. Scie. & Tech. SI/CH/AT/DE (m/f/d) Menges Slovenia Global Drug Development TECHNICAL R & D GDD Research & Development May 18, 2022
Global Biomarker Diagnostic Associate Director Basel Switzerland Global Drug Development OHD GDD Research & Development May 18, 2022
Principal Clinical Data Manager Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 18, 2022
Associate Director Clinical Data Mgmt Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 18, 2022
Clinical Study Manager (Remote) East Hanover, NJ USA Global Drug Development GDO GDD Research & Development May 18, 2022
Associate Director Regulatory Writer East Hanover, NJ USA Global Drug Development GDO GDD Research & Development May 18, 2022
Senior Medical Safety Lead- Respiratory & Allergy Hyderabad, AP India Global Drug Development CMO & PATIENT SAFETY GDD Research & Development May 17, 2022
Senior Expert - Science & Technology - Drug Substance Product Lead Durham, NC USA Global Drug Development TECHNICAL R & D GDD Research & Development May 17, 2022
RA CMC Director (Oncology) Basel Switzerland Global Drug Development REG AFFAIRS GDD Research & Development May 17, 2022
Senior Scientist – USP and Microbial Cell Banks (f/m/d) Kundl Austria Global Drug Development TECHNICAL R & D GDD Research & Development May 17, 2022
Principal Process & Training Lead Hyderabad, AP India Global Drug Development GDO GDD Research & Development May 17, 2022
Associate Director Data Operations-GDQ Hyderabad, AP India Global Drug Development QA GDD Quality May 17, 2022
Senior Manager, Quality Assurance Precision Medicine National United Kingdom Global Drug Development GDO GDD Quality May 17, 2022
Vigilance Process Manager Hyderabad, AP India Global Drug Development CMO & PATIENT SAFETY GDD Research & Development May 17, 2022
Head – P&O, Global Drug Development India Hyderabad, AP India Global Drug Development MGMT OFFICE GDD Human Resources May 16, 2022
Sr Clinical Research Associate CRA II Buenos Aires Argentina Global Drug Development GDO GDD Research & Development May 16, 2022
Technical Transfer Operations Lead Schaftenau Austria Global Drug Development TECHNICAL R & D GDD Research & Development May 16, 2022
Sr Expert, Science & Technology / Statistician (Durham, East Hanover) San Diego, CA USA Global Drug Development TECHNICAL R & D GDD Research & Development May 16, 2022
Clinical Development Director - Metabolic **80-100% Basel Switzerland Global Drug Development CARDIO-RENAL-METAB GDD Research & Development May 16, 2022

Novartis

Navigate
  • Patients and Caregivers
  • Healthcare Professionals
  • Researchers
  • Job Seekers
  • Journalists
  • Investors
  • Partners
  • Suppliers
Topics
  • Clinical Trials
  • COVID-19 Info Center
  • ESG
Explore
  • Stories
  • Diseases
  • Locations
  • Products
  • Novartis Pipeline
Novartis companies
  • Sandoz
  • Advanced Accelerator Applications
  • Gyroscope Therapeutics
Footer Bottom
© 2022 Novartis AG
  • Terms of Use
  • Privacy
  • Contacts
  • Cookie Settings
  • Site Map
  • Web Accessibility
  • Open Source
Novartis Site Directory
This site is intended for a global audience